4 June 2015 - Deborah Wilkes
Archived
Perrigo is acquiring a portfolio of OTC brands from GlaxoSmithKline Consumer Healthcare, including nicotine-replacement therapy (NRT) products, cold and flu remedies, and cold-sore treatments. The deal includes the NiQuitin NRT business in Europe, Brazil and Turkey, as well as the Nicotinell NRT business in Australia.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.